checkAd
    Startseite > Aktien > Fulcrum Therapeutics > Nachrichten
    Fulcrum Therapeutics Aktie
    7,5000
     
    USD
    -1,19 %
    -0,0900 USD
    Letzter Kurs 02:00:00 Nasdaq
    7,4800
     
    USD
    600 STK
    Geldkurs 09.05.24
    7,5000
     
    USD
    200 STK
    Briefkurs 09.05.24
    ISIN: US3596161097 · WKN: A2PM28 · SYM: FULC · USA

    Neueste Nachrichten

    Fulcrum Therapeutics to Participate in Upcoming May Conferences
    09.05.24 · globenewswire · Fulcrum Therapeutics
    Fulcrum Therapeutics Announces Publication of Results from Phase 2b Clinical Trial of Losmapimod in Facioscapulohumeral muscular dystrophy (ReDUX4) in The Lancet Neurology
    08.05.24 · globenewswire · Fulcrum Therapeutics
    Fulcrum Therapeutics to Host First Quarter 2024 Financial Results Conference Call and Webcast on Monday, May 13, 2024, at 8: 00 a.m. ET
    06.05.24 · globenewswire · Fulcrum Therapeutics
    Fulcrum Therapeutics to Participate at the Cantor Virtual Muscular Dystrophy Symposium
    28.03.24 · globenewswire · Fulcrum Therapeutics
    Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    22.03.24 · globenewswire · Fulcrum Therapeutics
    Fulcrum Therapeutics Appoints Patrick Horn M.D., Ph.D., as Chief Medical Officer
    18.03.24 · globenewswire · Fulcrum Therapeutics
    Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    08.03.24 · globenewswire · Fulcrum Therapeutics
    Fulcrum Therapeutics to Participate at the Leerink Partners Global Biopharma Conference
    05.03.24 · globenewswire · Fulcrum Therapeutics
    Fulcrum Therapeutics Announces Recent Business Highlights and Financial Results for Fourth Quarter and Full Year 2023
    27.02.24 · globenewswire · Fulcrum Therapeutics
    Fulcrum Therapeutics to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call and Webcast on Tuesday, February 27, 2024, at 8: 00 a.m. ET
    20.02.24 · globenewswire · Fulcrum Therapeutics
    Fulcrum Therapeutics to Participate at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
    06.02.24 · globenewswire · Fulcrum Therapeutics
    Fulcrum Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
    10.11.23 · globenewswire · Fulcrum Therapeutics